Publications
Specialty
Search
Oncology
04/19/2024
At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, David Siegel, MD, PhD, discusses the role of stem cell transplant for patients with myeloma over age 65 and argues that it is a viable treatment option for this patient population.
Podiatry Today, Podiatry
04/19/2024
Dr. McDannald dives deeper into referral streams and how to set yourself up for success.
Advances in Inflammatory Bowel Disease Network
04/19/2024
Dr David Hudesman, codirector of the Inflammatory Disease Center at NYU-Langone Health, reviews key points to consider when building an IBD program or working to expand an existing center.
Psych Congress Network
04/18/2024
When treating tardive dyskinesia (TD), the American Psychiatric Association (APA) recommends performing an assessment with a structured instrument (e.g., AIMS, DISCUS) how often?
Psych Congress Network
04/18/2024
When treating tardive dyskinesia (TD), the American Psychiatric Association (APA) recommends performing an assessment with a structured instrument (e.g., AIMS, DISCUS) how often?
Lymphoma, Leukemia & Myeloma Network
04/18/2024
At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Andrew Evens, DO, MBA, MSc, emphasizes the importance of continuing clinical trials for patients with Hodgkin lymphoma to gather valuable treatment data.
First Report Managed Care
04/18/2024
During a panel discussion at AMCP 2024, Sean Jeffery, PharmD, BCGP, FASCP, AGSF, Jay Rajda, MD, MBA, Shawn Wang, Chief AI Officer at Elevance Health, and Joseph Honcz, RPh, MBA, detailed case studies to examine the current and future influence of artificial intelligence (AI) on managed care in health care management and delivery systems. The discussion focused on practical strategies and implementation to enhance patient care and operational efficiencies.
Psych Congress Network, Neurology
04/18/2024
Insomnia symptoms, even if mild, were found to be associated with increased drinking over time, according to findings from the “first study to examine if objective circadian measures can predict future alcohol use in adults.”
First Report Managed Care
04/18/2024
Global trends in pharmaceutical pricing strategies and innovative contracting models, the increasing complexities of drug pricing, and the potential risks of an overinflated market bubble were discussed in a keynote session with Omar Ali, BSc(Hons)Pharm, DipClinPharm, MRPharmS, ACPP, at AMCP 2024.
EP Lab Digest
04/18/2024
Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists in assessing complex cardiac arrhythmias such as atrial fibrillation (AF), today announced presentations to be made at the Heart Rhythm Society 2024 meeting in Boston, May 16 to 19. In-person attendance and live online participation in a hybrid format will be available. Volta will host a demonstration of Volta AF-Xplorer™, and a Rhythm Theater featuring a panel of experts in the field moderated by Dr.
ePlasty, Surgery
04/18/2024
This report highlights key clinical findings of infantile hemangiomas, while also identifying "red flags" that necessitate urgent additional investigations and referral to a multidisciplinary team.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/18/2024
Using the national disclosure program Open Payments, the authors examined marketing-related payments from the LVAD manufacturer to cardiologists from 2016 to 2018, then linked these data to Medicare claims to determine which devices were subsequently used in beneficiaries.
EP Lab Digest
04/18/2024
April 18, 2024. St. Paul, Minnesota. Agitated Solutions, Incorporated (ASI) announced today that it has been issued a Medical Device Establishment License (MDEL) from Health Canada for its innovative Orbis™ Microbubble Generator that simplifies and streamlines the process of saline agitation and delivery for cardiac bubble studies. Orbis is the first tool to automatically agitate the saline with uniform, small bubbles that endure longer for visibility.
Pharmacy Learning Network
04/18/2024
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report. No details on the specific deviations were provided.
Oncology
04/18/2024
According to phase 3b results from the VENICE-1 trial, venetoclax monotherapy demonstrates durable responses in adult patients with relapsed/refractory chronic lymphocytic leukemia, including BCRi-pretreated patients.
Vascular Disease Management
04/18/2024
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Oncology
04/18/2024
Venetoclax with low-dose cytarabine is well-tolerated and highly effective among patients with acute myeloid leukemia at first measurable residual disease or oligoblastic relapse, according to a phase 2 study.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/18/2024
With a four-year, $2.07 million grant from the NIH, researchers plan to enclose a set of proteins designed to curb inflammation and a peptide to prevent fibrosis inside cleverly disguised drug-delivering smart nanoparticles. These nanoparticles would be delivered intravenously into the blood, which would take them directly to the heart.
Oncology
04/18/2024
According to results from the phase 3 ALINA trial, adjuvant alectinib significantly improved disease-free survival among patients with resected ALK-positive stage IB, II, or IIIA non-small cell lung cancer.
Oncology
04/18/2024
According to results from the phase 2 acelERA breast cancer study, giredestrant showed a favorable trend toward benefit in investigator-assessed progression-free survival among previously treated patients with ESR1-mutated, ER-positive, HER2-negative advanced breast cancer.
Current Issue
September 2024
Volume
Issue
Enter Your E-mail
EMSWorld Newsletter
